These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. HLA class II alleles and genetic predisposition to the antiphospholipid syndrome. Domenico Sebastiani G; Minisola G; Galeazzi M Autoimmun Rev; 2003 Oct; 2(6):387-94. PubMed ID: 14550881 [TBL] [Abstract][Full Text] [Related]
4. Genetic risk factors of thrombosis in the antiphospholipid syndrome. Castro-Marrero J; Balada E; Vilardell-Tarrés M; Ordi-Ros J Br J Haematol; 2009 Nov; 147(3):289-96. PubMed ID: 19659549 [TBL] [Abstract][Full Text] [Related]
5. Genetics of antiphospholipid syndrome. Atsumi T; Bertolaccini ML; Koike T Rheum Dis Clin North Am; 2001 Aug; 27(3):565-72, vi. PubMed ID: 11534260 [TBL] [Abstract][Full Text] [Related]
6. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests. Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167 [TBL] [Abstract][Full Text] [Related]
7. Antiphospholipid syndrome (APS): where does it come from? Sherer Y; Blank M; Shoenfeld Y Best Pract Res Clin Rheumatol; 2007 Dec; 21(6):1071-8. PubMed ID: 18068862 [TBL] [Abstract][Full Text] [Related]
8. Antiphospholipid syndrome: 30 years and our contribution. Koike T Int J Rheum Dis; 2015 Feb; 18(2):233-41. PubMed ID: 25524556 [TBL] [Abstract][Full Text] [Related]
9. Prothrombotic mechanisms based on the impairment of fibrinolysis in the antiphospholipid syndrome. Forastiero R; Martinuzzo M Lupus; 2008 Oct; 17(10):872-7. PubMed ID: 18827051 [TBL] [Abstract][Full Text] [Related]
10. An insight into the pathophysiology of thrombosis in antiphospholipid syndrome. Palomo IG; Segovia FM; Alarcon ML; Fuentes BY; Pereira JG; Rojas A; Forastiero R Front Biosci; 2007 May; 12():3093-103. PubMed ID: 17485284 [TBL] [Abstract][Full Text] [Related]
11. New autoantigens in the antiphospholipid syndrome. Alessandri C; Conti F; Pendolino M; Mancini R; Valesini G Autoimmun Rev; 2011 Aug; 10(10):609-16. PubMed ID: 21545849 [TBL] [Abstract][Full Text] [Related]
12. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209 [TBL] [Abstract][Full Text] [Related]
13. The role of TLR4 in pathophysiology of antiphospholipid syndrome-associated thrombosis and pregnancy morbidity. Xie H; Sheng L; Zhou H; Yan J Br J Haematol; 2014 Jan; 164(2):165-76. PubMed ID: 24180619 [TBL] [Abstract][Full Text] [Related]
14. Role of antiphospholipid score and anti-β2-glycoprotein I Domain I autoantibodies in the diagnosis of antiphospholipid syndrome. Mondejar R; González-Rodríguez C; Toyos-Sáenz de Miera FJ; Melguizo-Madrid E; Zohoury N; Mahler M; Romero Losquiño I; Fabiani F Clin Chim Acta; 2014 Apr; 431():174-8. PubMed ID: 24522162 [TBL] [Abstract][Full Text] [Related]
15. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome. Arnout J Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685 [TBL] [Abstract][Full Text] [Related]
16. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies. Cabiedes J; Cabral AR; Alarcón-Segovia D J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989 [TBL] [Abstract][Full Text] [Related]
18. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome. Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498 [TBL] [Abstract][Full Text] [Related]
19. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements. Žigon P; Podovšovnik A; Ambrožič A; Tomšič M; Hočevar A; Gašperšič N; Rotar Ž; Praprotnik S; Šemrl SS; Čučnik S Clin Rheumatol; 2019 Feb; 38(2):371-378. PubMed ID: 30099654 [TBL] [Abstract][Full Text] [Related]
20. First-Line, Non-Criterial Antiphospholipid Antibody Testing for the Diagnosis of Antiphospholipid Syndrome in Clinical Practice: A Combination of Anti-β Nakamura H; Oku K; Amengual O; Ohmura K; Fujieda Y; Kato M; Bohgaki T; Yasuda S; Atsumi T Arthritis Care Res (Hoboken); 2018 Apr; 70(4):627-634. PubMed ID: 28686816 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]